Random Forests, XGBoost, and Gradient Boosting in Biological Data Analysis

Random forest and gradient boosting algorithms, including XGBoost, have become dependable tools for analyzing biological data because they tolerate messy, mixed-type inputs without extensive preprocessing. These tree-based methods resist overfitting when properly tuned and generate feature importance scores that connect a prediction back to specific biological variables. This guide covers when to use each method, how to tune them, and how to interpret what they reveal about the underlying biology.

Why tree-based methods work well for biological data

Random forests and gradient boosting suit biological data because decision trees split on one variable at a time and require no assumption about data distribution or a linear relationship between predictors and outcome. Biological datasets are frequently high-dimensional, mix continuous and categorical variables, and include the kind of skewed distributions and zero inflation common in omics measurements, all of which tree-based methods handle natively.

This flexibility is especially valuable in high-dimensional settings such as gene expression or methylation data, where the number of measured features often exceeds the number of samples. Random forests are considered particularly well suited to this kind of complex, high-dimensional omics data, including data that is skewed or left censored by detection limits. That same tolerance for irregular feature structure extends to gradient boosting and XGBoost, which is why both families now appear routinely across genomics, imaging-derived features, and clinical biomarker panels.

Neither family requires feature scaling or normalization before training, since decision trees split on raw thresholds rather than distances or gradients that are sensitive to variable scale. This removes a preprocessing step that many other machine learning methods require, and it makes tree-based ensembles a practical entry point for researchers combining variables measured on very different scales, such as gene counts alongside clinical measurements.

Overfitting resistance is the other property that distinguishes tree-based ensembles from a single decision tree. A lone decision tree fits training data closely and generalizes poorly, but averaging or boosting many trees smooths out that instability. For a deeper grounding in the supervised learning concepts underlying these methods, a companion guide on machine learning methods for life science research covers model evaluation and validation practices that apply directly to tree-based workflows.

Random forests for genomics and biological data analysis

A random forest builds many decision trees, each trained on a bootstrapped sample of the data and a random subset of predictors at each split, then averages their predictions. This randomization decorrelates the individual trees, so their combined prediction error is lower than any single tree could achieve alone.

Because each tree in a random forest is grown independently, adding more trees does not increase the risk of overfitting the way additional boosting iterations can. This property makes random forests a forgiving default choice for biological applications such as classifying tumor subtypes from expression data, prioritizing candidate variants in genomics studies, or predicting compound activity from molecular descriptors, where a strong baseline result is needed before investing in more complex tuning.

Random forests also produce an internal estimate of prediction error through out-of-bag samples, observations left out of the bootstrap sample used to build a given tree. This out-of-bag error gives researchers a built-in validation signal without setting aside a separate test set, which is useful when sample sizes are limited, as they often are in clinical or preclinical biological studies.

Random forests are not without limitations for biological data. When predictors are highly correlated, as is common among coexpressed genes or linked genetic variants, importance scores can be split across correlated features in a way that understates any single variable's true relevance. Training hundreds of trees on large omics datasets also carries a real computational cost, though this is usually manageable with modern multicore hardware.

Gradient boosting and XGBoost for life science data

Gradient boosting builds trees sequentially, with each new tree fitting the errors, or residuals, left by the ensemble built so far. This sequential correction often gives gradient boosting a competitive edge in predictive accuracy on structured tabular data, though the size of that edge varies by dataset, and gradient boosting is more sensitive to hyperparameter choices than random forests are. Some benchmark comparisons find random forests match or outperform boosted trees on a given task, so neither method should be assumed superior without testing both.

XGBoost, short for extreme gradient boosting, improved on earlier gradient boosting implementations by adding regularization terms and more efficient tree-splitting calculations, which reduce overfitting and speed up training on large feature sets. These properties have made XGBoost a common choice for prognostic biomarker discovery from high-dimensional molecular data, including survival analyses where the outcome is time to an event such as disease progression.

Newer gradient boosting frameworks extend the same core idea with different strategies for growing trees and handling large feature sets, and the choice between them often comes down to dataset size and available computing resources rather than a single best answer. A recent tutorial on the XGBoost algorithm for drug development applications walks through this implementation logic in more detail for researchers new to the method. Tree-based ensembles also complement the deep learning methods used elsewhere in artificial intelligence-driven genomics workflows, often serving as an interpretable baseline or a feature-selection step alongside more complex variant-calling models.

XGBoost also handles missing values natively by learning an optimal default direction for each split during training, which is a practical advantage for biological datasets where missingness is common, such as incomplete clinical records or dropout in single-cell measurements. Its regularization terms penalize overly complex trees directly within the loss function, giving researchers a lever to control model complexity beyond simply limiting tree depth or the number of boosting rounds.

Table 1: Comparing practical characteristics of random forests and gradient boosting or XGBoost for biological data analysis.

Tuning random forest and XGBoost hyperparameters for biological data

Random forests need relatively little tuning because their two most influential settings, the number of trees and the number of predictors sampled at each split, have a wide range of values that perform well. Increasing the number of trees generally improves stability up to a point and then plateaus, so tuning effort is better spent on the number of predictors sampled at each split when feature counts are very high.

Gradient boosting and XGBoost require more careful tuning because their hyperparameters interact. Learning rate, the number of boosting rounds, and tree depth jointly control how quickly the model fits the training data, and getting the combination wrong risks either underfitting or memorizing noise in the training set. A 2025 study that used Bayesian optimization to tune random forest, XGBoost, and related gradient boosting algorithms for genomic selection in livestock found that tuning improved average prediction accuracy across every method tested. The best-performing algorithm still varied by trait, and XGBoost was not the strongest performer in that dataset, a reminder that tuning gains are dataset-dependent rather than universal.

Automated search strategies, including grid search, random search, and Bayesian or tree-structured approaches, each trade off differently between search thoroughness and computational cost. Grid search is exhaustive but expensive as the number of hyperparameters grows, while random and Bayesian methods sample the search space more efficiently and tend to find comparably strong configurations with fewer total training runs.

How Agentic AI Is Transforming the Modern Lab

This whitepaper examines how agentic AI is reshaping laboratory operations and what this shift means for the future of scientific discovery.
View Whitepaper

Advertisement

A practical tuning checklist for either method includes:

• Start with a wide, coarse hyperparameter search before narrowing to a fine-grained grid around promising values.
• Use cross-validation that respects biological group structure, keeping all samples from the same patient, batch, or cell line in the same fold.
• For gradient boosting, lower the learning rate and increase the number of boosting rounds together rather than tuning either alone.
• Monitor validation performance across boosting rounds and stop early once it plateaus or begins to decline.
• Revalidate tuned hyperparameters on an independent dataset before relying on them for a new sample type or platform.

Interpreting feature importance and SHAP values in biological data

Both random forests and gradient boosting produce feature importance scores that rank predictors by how much they contribute to model predictions, which is one reason these methods remain popular for biomarker discovery. Traditional importance measures based on impurity reduction or permutation are useful for a first pass but can be biased toward features with more possible split points or higher cardinality.

SHAP values address this limitation by allocating each prediction fairly among the contributing features using a game-theoretic approach, and a tree-specific algorithm makes this calculation efficient even for large ensembles. This approach has been used to reveal positional patterns in biological sequences that simple summary statistics missed entirely, showing that SHAP-based interpretation can surface biologically meaningful relationships beyond what raw feature counts suggest.

Combining many individual SHAP explanations also supports global model understanding, not just single-prediction interpretation. This kind of analysis has been used to explain tree ensembles globally in medical prediction problems, including identifying feature interactions and monitoring how a deployed model's behavior shifts over time. Researchers applying feature importance to biological data should treat a high-ranking feature as a candidate for further validation rather than confirmed evidence of a causal biological mechanism.

Summary visualizations that rank features by their average SHAP magnitude, alongside dependence plots that show how a single feature's contribution changes across its value range, give researchers two complementary views of model behavior. The first view highlights which variables matter most overall, while the second reveals whether a feature's relationship with the prediction is linear, threshold-like, or dependent on interactions with other variables.

Choosing random forests or gradient boosting for biological research

Random forests and gradient boosting, including XGBoost, both belong to the same family of tree-based ensemble methods, but they trade off differently between ease of use and predictive ceiling. Random forests reward researchers who want a robust result with minimal tuning, while gradient boosting rewards those willing to invest tuning effort for a potential accuracy gain on structured biological data.

Selecting between them, and tuning whichever is chosen, follow the same broader principle found across artificial intelligence and data science in life science research: match the method to the data, validate rigorously, and treat feature importance as a hypothesis-generating tool rather than a final answer.

This content includes text that has been created with the assistance of generative AI and has undergone editorial review before publishing. Technology Networks' AI policy can be found here.